- Research Digest
Researchers from Arbor Biotechnologies have developed a versatile, specific, and high-efficiency genome-editing platform and showed the therapeutic potential of Cas12i in mammalian cells for the first time.
07-22-2022Read More »
From human memory B cells, researchers at Merck & Co. have recently isolated over a hundred monoclonal antibodies that specifically target human metapneumovirus, a common cause of acute lower respiratory infection in children.
06-20-2022Read More »
Researchers at Uppsala University have recently developed novel CAR T cells that outcompete conventional ones and induce advantageous immunological responses against solid tumors in mouse models.
05-18-2022Read More »
Perturb-map is a new spatial functional genomics technology that unravels the mystery of tumor microenvironment and speeds up the discovery of new targets for better cancer therapies.
05-11-2022Read More »
Researchers from Sloan Kettering Cancer Center recently designed a new type of CAR T cell that overcomes many hurdles of regular CAR T cell therapy and greatly enhances the anti-tumor efficacy of genetically engineered T cells.
03-17-2022Read More »
Learn how investigators leverage the golden hamster model system to understand adaptive immune memory responses to SARS-CoV-2 and VOC.
01-17-2022Read More »
Researchers from Oslo University Hospital recently found an appealing cancer target named TdT for short, providing new "eyes" of immune system to detect cancer cells.
01-09-2022Read More »
Various vaccines based on different types of RNA are now under development to fight emerging SARS-CoV-2 variants, bringing new hopes for stopping the long-standing pandemic.
09-28-2021Read More »